Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Schlee

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Immunobiology|July 31, 2013
Master sensors of pathogenic RNA - RIG-I like receptorsMartin Schlee
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 13, 2010
The chase for the RIG-I ligand--recent advancesMartin Schlee, Gunther Hartmann
Nature Reviews. Immunology|July 26, 2016
Discriminating self from non-self in nucleic acid sensingMartin Schlee, Gunther Hartmann
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 1, 2006
siRNA and isRNA: two edges of one swordMartin Schlee, Veit Hornung, Gunther Hartmann
Immunity|July 14, 2021
DPP9 holds all the CARD8s for inflammasome regulationJulia Wegner, Alexander Kirchhoff, Martin Schlee
Signal Transduction and Targeted Therapy|July 10, 2021
The many faces of cGAS: how cGAS activation is controlled in the cytosol, the nucleus, and during mitosisAnna-Maria Herzner, Martin Schlee, Eva Bartok
Current Opinion in Immunology|July 26, 2008
Accessing the therapeutic potential of immunostimulatory nucleic acidsWinfried Barchet, Vera Wimmenauer, Martin Schlee, et al.
Handbook of Experimental Pharmacology|December 12, 2007
RNA recognition via TLR7 and TLR8Veit Hornung, Winfried Barchet, Martin Schlee, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 25, 2014
Enzymatic synthesis and purification of a defined RIG-I ligandMarion Goldeck, Martin Schlee, Gunther Hartmann, et al.
Frontiers in Immunology|March 20, 2023
Increased IKKϵ protein stability ensures efficient type I interferon responses in conditions of TBK1 deficiencyJulia Wegner, Charlotte Hunkler, Katrin Ciupka, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Immunobiology|July 31, 2013
Master sensors of pathogenic RNA - RIG-I like receptorsMartin Schlee
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 13, 2010
The chase for the RIG-I ligand--recent advancesMartin Schlee, Gunther Hartmann
Nature Reviews. Immunology|July 26, 2016
Discriminating self from non-self in nucleic acid sensingMartin Schlee, Gunther Hartmann
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 1, 2006
siRNA and isRNA: two edges of one swordMartin Schlee, Veit Hornung, Gunther Hartmann
Immunity|July 14, 2021
DPP9 holds all the CARD8s for inflammasome regulationJulia Wegner, Alexander Kirchhoff, Martin Schlee
Signal Transduction and Targeted Therapy|July 10, 2021
The many faces of cGAS: how cGAS activation is controlled in the cytosol, the nucleus, and during mitosisAnna-Maria Herzner, Martin Schlee, Eva Bartok
Current Opinion in Immunology|July 26, 2008
Accessing the therapeutic potential of immunostimulatory nucleic acidsWinfried Barchet, Vera Wimmenauer, Martin Schlee, et al.
Handbook of Experimental Pharmacology|December 12, 2007
RNA recognition via TLR7 and TLR8Veit Hornung, Winfried Barchet, Martin Schlee, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 25, 2014
Enzymatic synthesis and purification of a defined RIG-I ligandMarion Goldeck, Martin Schlee, Gunther Hartmann, et al.
Frontiers in Immunology|March 20, 2023
Increased IKKϵ protein stability ensures efficient type I interferon responses in conditions of TBK1 deficiencyJulia Wegner, Charlotte Hunkler, Katrin Ciupka, et al.
Pageof 7